Targeted Ablation at Stable Atrial Fibrillation Sources Improves Success Over Conventional Ablation in High-Risk Patients: A Substudy of the CONFIRM Trial

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1218-1226

  Baykaner, Tina ^a   Clopton, Paul ^a   Lalani, Gautam G ^a   Schricker, Amir A ^a   Krummen, David E ^a   Narayan, Sanjiv M ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOCAL IMPULSE AND ROTOR MODULATION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RECURRENT DISEASE; SLEEP DISORDERED BREATHING;

ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; TREATMENT OUTCOME;

EID: 84884594608     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.07.672     Document Type: Article

References (37)

1. Jongnarangsin K., Chugh A., Good E., et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. JCardiovasc Electrophysiol 2008, 19:668-672.
2. Chen M.S., Marrouche N.F., Khaykin Y., et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. JAm Coll Cardiol 2004, 43:1004-1009.
3. Mohanty S., Mohanty P., Di Biase L., et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. JAm Coll Cardiol 2012, 59:1295-1301.
4. Chilukuri K., Dalal D., Gadrey S., et al. Aprospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. JCardiovasc Electrophysiol 2010, 21:521-525.
5. Allessie M.A., Bonke F.I., Schopman F.J. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977, 41:9-18.
6. Jalife J. Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc Res 2011, 89:766-775.
7. Ryu K., Shroff S.C., Sahadevan J., et al. Mapping of atrial activation during sustained atrial fibrillation in dogs with rapid ventricular pacing induced heart failure: evidence for a role of driver regions. JCardiovasc Electrophysiol 2005, 16:1348-1358.
8. Narayan S.M., Krummen D.E., Shivkumar K., et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. JAm Coll Cardiol 2012, 60:628-636.
9. Shivkumar K., Ellenbogen K.A., Hummel J.D., et al. Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation. JCardiovasc Electrophysiol 2012, 23:1277-1285.
10. Kowal R, Daubert J, Day J, etal. Results of focal impulse and rotor modulation (FIRM) for atrial fibrillation are equivalent between patients treated in san diego compared with sites new to FIRM ablation: an extended multi-center experience. Paper presented at: Heart Rhythm Society 2013 Scientific Sessions. May 8-11, 2013; Denver, CO.
11. Narayan S.M., Krummen D.E., Clopton P., et al. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM (conventional ablation for AF with or without focal impulse and rotor modulation) trial. JAm Coll Cardiol 2013, 62:138-147.
12. Calkins C.H. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm 2012, 9:632-696.
13. Calvo D., Atienza F., Jalife J., et al. High-rate pacing-induced atrial fibrillation effectively reveals properties of spontaneously occurring paroxysmal atrial fibrillation in humans. Europace 2012, 14:1560-1566.
14. Narayan S.M., Krummen D.E., Rappel W.J. Clinical mapping approach to identify rotors and focal beats in human atrial fibrillation. JCardiovasc Electrophysiol 2012, 23:447-454.
15. Konings K., Kirchhof C., Smeets J., et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994, 89:1665-1680.
16. Cuculich P.S., Wang Y., Lindsay B.D., et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation 2010, 122:1364-1372.
17. Levey A.S., Coresh J., Balk E., et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
18. Steiger J.H. Tests for comparing elements of a correlation matrix. Psychol Bull 1980, 87:245-251.
19. Nattel S. From guidelines to bench: implications of unresolved clinical issues for basic investigations of atrial fibrillation mechanisms. Can J Cardiol 2011, 27:19-26.
20. Krahn A.D., Manfreda J., Tate R.B., et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995, 98:476-484.
21. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292:2471-2477.
22. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. JAm Coll Cardiol 2007, 49:565-571.
23. Iwasaki Y.K., Shi Y., Benito B., et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 2012, 9:1409-1416.e1.
24. Khan A.M., Lubitz S.A., Sullivan L.M., et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013, 127:33-38.
25. Cai L., Yin Y., Ling Z., et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013, 164:82-87.
26. Ng C.Y., Liu T., Shehata M., et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011, 108:47-51.
27. Berruezo A., Tamborero D., Mont L., et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007, 28:836-841.
28. Klos M., Calvo D., Yamazaki M., et al. Atrial septopulmonary bundle of the posterior left atrium provides a substrate for atrial fibrillation initiation in a model of vagally mediated pulmonary vein tachycardia of the structurally normal heart. Circ Arrhythm Electrophysiol 2008, 1:175-183.
29. Oakes R.S., Badger T.J., Kholmovski E.G., et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009, 119:1758-1767.
30. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008, 1:62-73.
31. Patterson E., Lazzara R., Szabo B., et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. JAm Coll Cardiol 2006, 47:1196-1206.
32. Comtois P., Nattel S. Impact of tissue geometry on simulated cholinergic atrial fibrillation: a modeling study. Chaos 2011, 21:013108.
33. Roux F., D'Ambrosio C., Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000, 108:396-402.
34. Kato T., Yamashita T., Sekiguchi A., et al. What are arrhythmogenic substrates in diabetic rat atria?. JCardiovasc Electrophysiol 2006, 17:890-894.
35. de Divitiis O., Fazio S., Petitto M., et al. Obesity and cardiac function. Circulation 1981, 64:477-482.
36. Naruse Y., Tada H., Satoh M., et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 2013, 10:331-337.
37. Charitos E.I., Stierle U., Ziegler P.D., et al. Acomprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation 2012, 126:806-814.